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Introduction
In patients without pre-existing diabetes, hyperglycaemia
during critical illness is associated with adverse outcomes.
However, recent observational data suggest that in patients
with pre-existing poorly controlled type 2 diabetes
(defined as an HbA1c ≥7%) prior to their acute illness, tar-
geting glucose concentrations < 10mmol/l is associated
with harm [1]. Accordingly a higher glucose target may
benefit these patients.
Objectives
To determine whether more liberal glucose targets in criti-
cally ill patients with pre-existing poorly controlled type 2
diabetes increases time weighted mean glucose concentra-
tion, attenuates hypoglycaemia, and appears overtly safe.
Methods
Prospective, open-label, sequential period, pilot study of 86
patients with poorly controlled type 2 diabetes (admission
HbA1c ≥ 7.0%) and a blood glucose concentration >
10mmol/L requiring admission to the Intensive Care Unit
(ICU) and administration of insulin. The ‘control’ patients
(n = 53) were consecutively admitted during a 6 month
period and the ‘intervention’ patients (n = 33) were
admitted during a subsequent 6 month period. During the
‘control’ period blood glucose was targeted between
6-10mmol/l, whereas during the ‘intervention’ period the
target was 10-14mmol/l. Time weighted mean glucose was
calculated and recorded blood glucose concentrations <
4.0mmol/l considered as an hypoglycaemic episode for
each patient. Data are mean (SE) or median [IQR] and
analysed using independent samples t-test, Mann-Whitney
test, Chi-squared test, Linear and Logistic regression as
appropriate.
Results
The groups were well matched in terms of age (Control:
64.0 (2.0) vs Intervention: 62.6 (2.0) years), admission
HbA1c (8.5 (0.2) vs 8.8 (0.2)%), APACHE II score (20.4
(1.0) vs 20.5 (1.2)) and Charlson Comorbidity Index (4.5
(0.3) vs 4.3 (0.3)). More liberal targets resulted in greater
time weighted mean glucose concentrations (TWGluco-
seday0-7 9.3 (0.3) vs 10.2 (0.4) mmol/l, P = 0.04) and
there was a trend towards fewer patients with hypogly-
caemic episodes (34% vs 16% of patients, P = 0.07).
There was no difference in ICU mortality (10 [19%] vs 6
[18%], P = 0.94) or 90-day mortality (19 [36%] vs 12
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Figure 1 Mean time weighted glucose between groups.
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[36%], P = 0.96). ICU length of stay was shorter in the
‘control’ period (3.5 [4.0] vs 6.3 [8.7] days, P = 0.01)
with significance persisting when adjusting for APACHE
scores and Charlson Comorbidity Index (P = 0.04).
Conclusions
In critically ill patients with pre-existing poorly controlled
type 2 diabetes, more liberal glucose targets increase mean
glucose concentrations may reduce the incidence of
insulin- induced hypoglycaemia, and appear to be overtly
safe. Prospective studies using larger cohorts are indicated.
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